Position in ATYR
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,746
-$2,068 QoQ
Shares Held
11,300
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 90 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gladstone Institutional Advisory LLC holds $1,952,269 across 9 Biotechnology names. ATYR ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GPCR |
Structure Therapeutics Inc.
|
13,275 | $712,469 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
50,818 | $444,911 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
9,527 | $371,648 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
383 | $238,815 | |
| 5 | GALT |
Galectin Therapeutics Inc
|
23,900 | $110,896 | |
| 6 | AVXL |
Anavex Life Sciences Corp.
|
17,671 | $45,767 | |
| 7 | CRDF |
Cardiff Oncology, Inc.
|
13,000 | $16,900 | |
| 8 | ATYR |
aTYR PHARMA INC
This page
|
11,300 | $6,746 |
All Filings in ATYR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,746 | 11,300 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $8,814 | 11,300 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,847 | 11,300 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,589 | 13,300 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $54,756 | 10,800 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||